Serum dehydroepiandrosterone sulfate levels predict longevity in men: 27-Year follow-up study in a community-based cohort (Tanushimaru study)

Journal of the American Geriatrics Society

Volumn 56, Issue 6, 2008, Pages 994-998

  Enomoto, Mika ^a   Adachi, Hisashi ^a   Fukami, Ako ^a   Furuki, Kumiko ^a   Satoh, Akira ^a   Otsuka, Maki ^a   Kumagae, Shun Ichi ^a   Nanjo, Yasuki ^a   Shigetoh, Yoshiyuki ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenal secreted hormone; Antiaging; Epidemiology; Mortality

Indexed keywords

PRASTERONE SULFATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HUMAN; MALE; MORTALITY; RISK ASSESSMENT; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DEHYDROEPIANDROSTERONE; FEMALE; FORECASTING; HUMANS; JAPAN; KAPLAN-MEIERS ESTIMATE; LONGEVITY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 44649172523     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.01692.x     Document Type: Article

References (20)

1. Labrie F, Luu-The V, Belanger A et al. Is dehydroepiandrosterone a hormone? J Endocrinol 2005 187 : 169 196.
2. Yen SSC. Dehydroepiandrosterone sulfate and longevity: New clues for an old friend. Proc Natl Acad Sci USA 2001 98 : 8167 8169.
3. Roth GS, Lane MA, Ingram DK et al. Biomarkers of caloric restriction may predict longevity in humans. Science 2002 297 : 811.
4. Feldman HA, Johannes CB, Araujo AB et al. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: Prospective results from the Massachusetts Male Aging Study. Am J Epidemiol 2001 153 : 79 89.
5. Barrett-Connor E, Goodman-Gruen D. The epidemiology of DHEAS and cardiovascular disease. Ann N Y Acad Sci 1995 774 : 259 270.
6. Hautanen A, Manttari M, Manninen V et al. Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study. Athrosclerosis 1994 105 : 191 200.
7. Newcomer LM, Manson JE, Barbieri RL et al. Dehydroepiandrosterone sulfate and the risk of myocardial infarction in US male physicians: A prospective study. Am J Epidemiol 1994 140 : 870 875.
8. Khaw K-T. Dehydroepiandrosterone, dehydropepiandrosterone sulphate and cardiovascular disease. J Endocrinology 1996 150 : S149 S153.
9. Mazat L, Lafont S, Berr C et al. Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: Relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc Natl Acad Sci USA 2001 98 : 8145 8150.
10. Barrett-Connor E, Khaw K-T, Yen SSC. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986 315 : 1519 1524.
11. Keys A, Aravanis C, Blackburn H et al. Epidemiological studies related to coronary heart disease: Characteristics of men aged 40-59 in seven countries. Acta Med Scand Suppl 1967 460 : 1 392.
12. Orentreich N, Brind JL, Rizer RL et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984 59 : 551 555.
13. Sekihara H, Osawa N, Ibayashi H. A radioimmunoassay for serum dehydroepiandrosterone sulfate. Steroids 1972 20 : 813 824.
14. Koga Y, Hashimoto R, Adachi H et al. Recent trends in cardiovascular disease and risk factor in Seven Countries Study. In : Keys A, Toshima H, Blackburn H, editors. Lessons for Science from the Seven Countries Study: A 35-Year Collaborative Experience in Cardiovascular Disease Epidemiology. Tokyo : Springer Verlag, 1994. 63 74.
15. International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Geneva: World Health Organization, 2003.
16. Barrett-Connor E, Edelstein SL. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: The Rancho Bernardo Study. J Am Geriatr Soc 1994 42 : 420 423.
17. Parker Jr. CR, Mixon RL, Brissie RM et al. Aging alters zonation in the adrenal cortex of men. J Clin Endocrinol Metab 2005 82 : 3898 3901.
18. Sulcova J, Hill M, Hampl R et al. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol 1997 154 : 57 62.
19. Kiechl S, Willeit J, Bonora E et al. No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study (Bruneck Study). Arterioscler Thromb Vasc Biol 2000 20 : 1094 1100.
20. Barrett-Connor E, Goodman-Gruen D. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women - The Rancho Bernardo Study. Circulation 1995 91 : 1757 1760.